Sentinel lymph node biopsy, validated in melanoma staging, is currently und
er investigation for breast cancer staging. Reports suggest that the sentin
el lymph node has a high predictive value in determining the presence of ax
illary metastases. Identification of a sentinel lymph node that is free of
metastatic tumor cells may eliminate the necessity of performing a standard
axillary lymph node dissection with its attendant morbidity. Numerous tech
niques are utilized to identify the sentinel node with approximately the sa
me success rate. This paper will address some of the controversial areas of
sentinel lymph node biopsy and offer art option for physicians who want to
develop a sentinel lymph node program in their hospital.